TD Cowen Initiates Coverage On Astrana Health with Buy Rating, Announces Price Target of $66
Portfolio Pulse from Benzinga Newsdesk
TD Cowen has initiated coverage on Astrana Health with a Buy rating and set a price target of $66.
October 14, 2024 | 9:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen has initiated coverage on Astrana Health with a Buy rating and a price target of $66, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $66 by TD Cowen suggests a positive sentiment towards Astrana Health's stock. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100